Aqueous based polymeric dispersion: Plackett–Burman design for screening of formulation variables of Atenolol Gastrointestinal Therapeutic System

S.V Sastry, M.A Khan
{"title":"Aqueous based polymeric dispersion: Plackett–Burman design for screening of formulation variables of Atenolol Gastrointestinal Therapeutic System","authors":"S.V Sastry,&nbsp;M.A Khan","doi":"10.1016/S0031-6865(97)00052-6","DOIUrl":null,"url":null,"abstract":"<div><p><span><span>Bilayered osmotically controlled Gastrointestinal Therapeutic System of atenolol has been obtained by using </span>cellulose acetate<span> pseudolatex prepared by polymer emulsification method. Various factors such as orifice size, coating thickness, amount and nature of polymeric excipients, and amount of osmotic agent influence the drug release from GITS. Therefore, in the present study a 7-factor, 12-run Plackett–Burman screening design was employed to evaluate the formulation variables for atenolol GITS coated with CA pseudolatex. The variables studied were orifice size, %coating weight gain, amounts of sodium chloride, Polyox® N80 and 303, and Carbopol® 934P and 974P on drug release. The screening design has revealed that orifice size, %coating weight gain and amount of Carbopol® 934P have prominent influence on in-vitro atenolol release. The response variable was cumulative percent atenolol released (</span></span><em>Y</em>) in 24 h with constraints on percent release at 2, 6, 12 and 18 h. The polynomial equation obtained was <em>Y</em><sub>24</sub>=149.82−0.13<em>X</em><sub>1</sub>−0.34<em>X</em><sub>2</sub>+0.06<em>X</em><sub>3</sub>−0.13<em>X</em><sub>4</sub>−0.23<em>X</em><sub>5</sub>−76.25<em>X</em><sub>6</sub>−2.46<em>X</em><sub>7</sub>. The results indicated that the drug release under constrained conditions was influenced by the factors with decreasing order of importance as %coating weight gain&gt;Carbopol® 934P&gt;Polyox® N80&gt;Carbopol® 974P&gt;Polyox® 303&gt;amount of sodium chloride&gt;orifice size.</p></div>","PeriodicalId":19830,"journal":{"name":"Pharmaceutica acta Helvetiae","volume":"73 2","pages":"Pages 105-112"},"PeriodicalIF":0.0000,"publicationDate":"1998-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0031-6865(97)00052-6","citationCount":"39","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutica acta Helvetiae","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0031686597000526","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 39

Abstract

Bilayered osmotically controlled Gastrointestinal Therapeutic System of atenolol has been obtained by using cellulose acetate pseudolatex prepared by polymer emulsification method. Various factors such as orifice size, coating thickness, amount and nature of polymeric excipients, and amount of osmotic agent influence the drug release from GITS. Therefore, in the present study a 7-factor, 12-run Plackett–Burman screening design was employed to evaluate the formulation variables for atenolol GITS coated with CA pseudolatex. The variables studied were orifice size, %coating weight gain, amounts of sodium chloride, Polyox® N80 and 303, and Carbopol® 934P and 974P on drug release. The screening design has revealed that orifice size, %coating weight gain and amount of Carbopol® 934P have prominent influence on in-vitro atenolol release. The response variable was cumulative percent atenolol released (Y) in 24 h with constraints on percent release at 2, 6, 12 and 18 h. The polynomial equation obtained was Y24=149.82−0.13X1−0.34X2+0.06X3−0.13X4−0.23X5−76.25X6−2.46X7. The results indicated that the drug release under constrained conditions was influenced by the factors with decreasing order of importance as %coating weight gain>Carbopol® 934P>Polyox® N80>Carbopol® 974P>Polyox® 303>amount of sodium chloride>orifice size.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
水基聚合物分散体:阿替洛尔胃肠道治疗系统配方变量筛选的Plackett-Burman设计
采用聚合物乳化法制备醋酸纤维素假酸酯,制备了阿替洛尔双层渗透控制胃肠道治疗系统。孔口大小、包被厚度、高分子赋形剂的用量和性质、渗透剂的用量等因素影响GITS的药物释放。因此,本研究采用7因素,12次Plackett-Burman筛选设计来评估CA假胶粘剂包被阿替洛尔GITS的配方变量。研究的变量包括孔口尺寸、包膜增重%、氯化钠、Polyox®N80和303的用量以及Carbopol®934P和974P对药物释放的影响。筛选设计表明,孔孔尺寸、包被增重%和caropol®934P用量对阿替洛尔体外释放有显著影响。响应变量为24 h累积阿替洛尔释放率(Y),并以2、6、12、18 h的释放率为约束条件,得到的多项式方程为Y24=149.82−0.13X1−0.34X2+0.06X3−0.13X4−0.23X5−76.25X6−2.46X7。结果表明:约束条件下影响药物释放的因素依次为包衣增重% gt、Carbopol®934P>、Polyox®N80>、Carbopol®974P>、Polyox®303>、氯化钠用量>、孔口尺寸;
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Editorial Stability studies of aspirin–magaldrate double layer tablets Spectrophotometric determination of aluminium in pharmaceutical preparations by azo dyes of 1,2,4-triazole series Improvement of water solubility and in vitro dissolution rate of gliclazide by complexation with β-cyclodextrin1 Spectrofluorimetric analysis of certain 4-quinolone in pharmaceuticals and biological fluids
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1